[go: up one dir, main page]

ZA987689B - 3-descladinose 6-O substituted erythromycin derivatives - Google Patents

3-descladinose 6-O substituted erythromycin derivatives

Info

Publication number
ZA987689B
ZA987689B ZA987689A ZA987689A ZA987689B ZA 987689 B ZA987689 B ZA 987689B ZA 987689 A ZA987689 A ZA 987689A ZA 987689 A ZA987689 A ZA 987689A ZA 987689 B ZA987689 B ZA 987689B
Authority
ZA
South Africa
Prior art keywords
descladinose
erythromycin derivatives
substituted erythromycin
substituted
derivatives
Prior art date
Application number
ZA987689A
Other languages
English (en)
Inventor
Yat Sun Or
Leping Li
Michael J Rupp
Daniel T Chu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of ZA987689B publication Critical patent/ZA987689B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA987689A 1997-09-02 1998-08-25 3-descladinose 6-O substituted erythromycin derivatives ZA987689B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92168897A 1997-09-02 1997-09-02

Publications (1)

Publication Number Publication Date
ZA987689B true ZA987689B (en) 1999-02-24

Family

ID=25445830

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA987689A ZA987689B (en) 1997-09-02 1998-08-25 3-descladinose 6-O substituted erythromycin derivatives

Country Status (9)

Country Link
EP (1) EP1027360A2 (xx)
JP (1) JP2001515844A (xx)
AR (1) AR017260A1 (xx)
AU (1) AU8925398A (xx)
CA (1) CA2301642A1 (xx)
CO (1) CO4960636A1 (xx)
SA (1) SA99191151A (xx)
WO (1) WO1999011651A2 (xx)
ZA (1) ZA987689B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA11753A (en) 1999-01-27 2005-07-19 Pfizer Prod Inc Ketolide antibiotics.
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
US6713615B2 (en) 2000-08-14 2004-03-30 Taisho Pharmaceutical Co., Ltd. Process for producing erythromycin derivative
TWI246515B (en) * 2001-05-30 2006-01-01 Abbott Lab An arylation method for the functionalization of O-allyl erythromycin derivatives
US6825172B2 (en) 2002-05-31 2004-11-30 Janssen Pharmaceutica, Nv 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
CA2591746A1 (en) 2004-12-21 2006-06-29 Pfizer Products Inc. Macrolides
CN105418706B (zh) * 2015-10-27 2019-05-17 华南理工大学 一种大环内酯类抗菌化合物及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421429D0 (en) * 1984-08-23 1984-09-26 Beecham Group Plc Chemical compounds
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
GB8521402D0 (en) * 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
WO1997017356A1 (en) * 1995-11-08 1997-05-15 Abbott Laboratories Tricyclic erythromycin derivatives
AU2340797A (en) * 1996-05-07 1997-11-26 Abbott Laboratories 6-o-substituted erythromycins and method for making them
AU4472797A (en) * 1996-10-31 1998-05-22 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
JP2000198795A (ja) * 1996-10-31 2000-07-18 Taisho Pharmaceut Co Ltd エリスロマイシンa誘導体

Also Published As

Publication number Publication date
AU8925398A (en) 1999-03-22
AR017260A1 (es) 2001-09-05
SA99191151A (ar) 2005-12-03
WO1999011651A3 (en) 1999-05-06
EP1027360A2 (en) 2000-08-16
JP2001515844A (ja) 2001-09-25
WO1999011651A2 (en) 1999-03-11
CO4960636A1 (es) 2000-09-25
CA2301642A1 (en) 1999-03-11

Similar Documents

Publication Publication Date Title
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
GB9702194D0 (en) Sulphonide derivatives
AU9277698A (en) 9-amino-3-keto erythromycin derivatives
HUP0100566A3 (en) Novel erythromycin derivatives
HUP9801168A3 (en) Triazinylaminostilbene derivatives
HUP0004282A3 (en) 2-halo-6-0-substituted ketolide derivatives
IL134220A0 (en) 6,9-bridged erythromycin derivatives
IL134996A0 (en) 6,11-bridged erythromycin derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
ZA987689B (en) 3-descladinose 6-O substituted erythromycin derivatives
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
AU6932098A (en) Erythromycin derivatives
GB9725541D0 (en) Amino-benzothiazole derivatives
AU1504899A (en) Erythromycin derivatives
IL130971A0 (en) Gemcitabine derivatives
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
ZA983116B (en) Arylsecocholadiene derivatives
IL132482A0 (en) Multicyclic erythromycin derivatives
IL131159A0 (en) 4-Aminoethoxyindazole derivatives
GB9700702D0 (en) Erythromycin derivatives
GB9706753D0 (en) Aralkoxy-morphinan derivatives
SI1005445T1 (en) N-alkanoylphenylalanine derivatives